# Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma

> **NCT00978120** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 390 (actual)

## Conditions studied

- H1N1 Influenza Virus

## Interventions

- **BIOLOGICAL:** H1N1 vaccine high dose
- **BIOLOGICAL:** H1N1 vaccine low dose

## Key facts

- **NCT ID:** NCT00978120
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 390 (ACTUAL)
- **Last updated:** 2012-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978120, "Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00978120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*